(HOWL) Werewolf Therapeutics - Performance -84.1% in 12m
Compare HOWL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-79.58%
#134 in Group
Rel. Strength
2.16%
#7785 in Universe
Total Return 12m
-84.12%
#180 in Group
Total Return 5y
-94.60%
#135 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: HOWL (-84.1%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: HOWL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for HOWL
| Total Return (including Dividends) | HOWL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 38.07% | 11.81% | 13.81% |
| 3 Months | -34.59% | -13.61% | -6.30% |
| 12 Months | -84.12% | -12.29% | 10.65% |
| 5 Years | -94.60% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | HOWL | XBI | S&P 500 |
| 1 Month | 72.1% | 72.9% | 83% |
| 3 Months | -85.9% | -83% | -75.3% |
| 12 Months | -93.2% | -51.6% | 50.1% |
| 5 Years | -77.1% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #131 | 23.5% | 21.3% |
| 3 Month | #154 | -24.3% | -30.2% |
| 12 Month | #180 | -81.9% | -85.7% |
| 5 Years | #124 | -90.6% | -96.2% |
FAQs
Does HOWL Werewolf Therapeutics outperforms the market?
No,
over the last 12 months HOWL made -84.12%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months HOWL made -34.59%, while XBI made -13.61%.
Over the last 3 months HOWL made -34.59%, while XBI made -13.61%.
Performance Comparison HOWL vs Indeces and Sectors
HOWL vs. Indices HOWL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.28% | 24.3% | -57.2% | -94.8% |
| US NASDAQ 100 | QQQ | -1.47% | 20.7% | -57.4% | -95.8% |
| US Dow Jones Industrial 30 | DIA | -1.69% | 28.1% | -56.9% | -91.8% |
| German DAX 40 | DAX | -1.26% | 23.1% | -83.5% | -110% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.46% | 26.2% | -58.0% | -91.5% |
| Hongkong Hang Seng | HSI | -4.45% | 18.1% | -65.6% | -97.8% |
| India NIFTY 50 | INDA | 3.64% | 33.2% | -57.7% | -83.9% |
| Brasil Bovespa | EWZ | -2.33% | 20.8% | -65.9% | -75.8% |
HOWL vs. Sectors HOWL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.92% | 24.7% | -64.3% | -106% |
| Consumer Discretionary | XLY | -1.66% | 23.8% | -56.3% | -98.4% |
| Consumer Staples | XLP | -0.42% | 31.5% | -64.2% | -93.2% |
| Energy | XLE | -1.10% | 31.3% | -50.6% | -74.7% |
| Financial | XLF | -2.38% | 24.6% | -64.3% | -107% |
| Health Care | XLV | 1.73% | 37.2% | -52.2% | -80.1% |
| Industrial | XLI | -2.97% | 21.3% | -58.7% | -95.1% |
| Materials | XLB | -1.08% | 24.5% | -52.3% | -78.9% |
| Real Estate | XLRE | 0.04% | 26.5% | -58.0% | -99.6% |
| Technology | XLK | -2.36% | 16.9% | -54.4% | -91.2% |
| Utilities | XLU | -1.33% | 28.5% | -64.9% | -102% |
| Aerospace & Defense | XAR | -3.26% | 16.9% | -68.7% | -111% |
| Biotech | XBI | 5.31% | 26.3% | -37.1% | -71.8% |
| Homebuilder | XHB | -1.75% | 26.6% | -44.0% | -76.6% |
| Retail | XRT | -3.18% | 23.4% | -53.0% | -82.6% |